Colombia Legalizes Medical Cannabis Flower Sales in Pharmacies Under Decree 1138 of 2025” ✅
🇨🇴 Colombia Gives the Green Light to Medical Cannabis Flower Sales in Pharmacies: What Changes in 2025
By Smokerolla Team
🌿 A Historic Step for Colombia’s Cannabis Industry
Colombia has taken another major step toward becoming a Latin American leader in medical cannabis regulation. With the enactment of Decree 1138 of 2025, the government has officially authorized the sale of dried cannabis flower for medical purposes through licensed pharmacies and drugstores, under medical prescription.
This measure represents a major shift: for the first time, patients will have legal access to the natural cannabis flower—not just oils, extracts, or capsules—broadening therapeutic options and strengthening Colombia’s domestic cannabis supply chain.
⚖️ What Decree 1138 of 2025 Allows
Issued by Colombia’s Ministry of Health and Ministry of Justice, Decree 1138 expands the country’s regulatory framework for medical cannabis. Key provisions include:
- Authorization for pharmacies and drugstores to sell dried cannabis flower with a valid medical prescription.
- Licensed national production with full traceability and pharmaceutical-grade quality standards.
- Medical and veterinary use under professional supervision.
- Inclusion of SMEs in the production and distribution chain.
- Strict sanitary and safety controls for certified products.
The measure aims to boost Colombia’s medical cannabis economy, promote pharmaceutical innovation, and limit the illegal market.
💊 What It Means for Patients
Patients suffering from conditions such as epilepsy, chronic pain, anxiety, insomnia, and inflammation can now access more personalized treatments. Until now, most had to rely on imported or high-cost extracts and oils.
- Better accessibility: Pharmacies will dispense cannabis directly to patients.
- Safety and traceability: Each batch will come from licensed, quality-controlled sources.
- Therapeutic diversity: Different cannabis strains will allow more precise prescriptions.
This marks an important step toward an integrated healthcare model where cannabis medicine becomes part of mainstream medical practice.
💼 Industry Impact: New Opportunities Ahead
Beyond patients, Decree 1138 opens doors to an entirely new phase of economic growth for Colombia’s cannabis sector. Thanks to its favorable climate, agricultural expertise, and progressive laws, Colombia is positioned to become a regional hub for medical cannabis exports.
- Job creation in rural and agricultural sectors.
- Empowerment of local SMEs through inclusion in the legal supply chain.
- Expansion of the domestic pharmaceutical market.
- Stronger international reputation as a trusted cannabis source.
🔥 Smokerolla and the New Era of Medical Cannabis Culture
At Smokerolla, we celebrate this as a positive step toward responsible, inclusive, and modern cannabis regulation in Latin America. Although the decree focuses on medical use, its effects will ripple across the broader cannabis ecosystem—from education to accessories that support safe, conscious consumption.
In this new era, high-quality accessories such as vaporizers, grinders, and odor-proof storage solutions are essential for patients seeking precision, hygiene, and control in their therapeutic use.
“The future of medical cannabis depends not only on legislation but also on education, responsibility, and access to quality products.”
— Smokerolla Team
🔍 What Still Needs to Be Regulated
While Decree 1138 is already official, additional regulations are pending. The ministries will need to establish implementation guidelines—technical protocols, pharmacy authorizations, and inspection standards—before full execution.
It’s important to note that this decree does not legalize recreational cannabis use. Adult-use legalization remains under discussion in Congress and may require further legislation.
🌎 Colombia’s Place on the Latin American Cannabis Map
With this decision, Colombia joins other countries like Uruguay, Argentina, and Mexico that have expanded medical cannabis access. However, including dried flower in pharmacy sales makes Colombia a regional pioneer and a reference in public health policy.
✍️ Conclusion
Allowing pharmacies to sell medical cannabis flower is a historic milestone for Colombia and the region. It reflects a shift toward normalization, patient safety, and science-driven regulation—while empowering small growers and ethical businesses.
At Smokerolla, we remain committed to sharing trustworthy, up-to-date information about global cannabis progress and promoting a culture of conscious, responsible, and sustainable consumption.
